Feng Zizhao, Cheng Wenjie, Ma Mingyang, Yu Chenwei, Zhang Ye, Lu Liqun, Wang Hao, Gui Lang, Xu Dan, Dong Chuanfu
National Pathogen Collection Center for Aquatic Animals, Shanghai Ocean University, Shanghai 201306, China.
National Demonstration Center for Experimental Fisheries Science Education, Shanghai Ocean University, Shanghai 201306, China.
Vaccines (Basel). 2023 Dec 30;12(1):43. doi: 10.3390/vaccines12010043.
2 (CyHV-2) is a pathogen that causes significant losses to the global aquaculture industry due to mass mortality in crucian carp and goldfish. This study demonstrates that the ORF55/ORF57 deletion mutants CyHV-2-Δ55-CP and CyHV-2-Δ57-CP obtained through homologous recombination replicate effectively within the caudal fin of (GiCF) cells and exhibit morphologies similar to the CyHV-2 wild-type strain. Both mutants demonstrated a decrease in virulence, with CyHV-2-Δ57-CP exhibiting a more significant reduction. This serves as a reference for the subsequent development of recombinant attenuated vaccines against CyHV-2. Additionally, both mutants expressed the inserted RGNNV-CP (capsid protein of ) fusion protein gene, and inoculation with CyHV-2-Δ57-CP-infected GiCF cell lysates elicited an antibody response in the grouper. These results indicate that, while ORF55 and ORF57 genes of CyHV-2 are not required for viral replication in vitro, they do play a role in virulence in vivo. Additionally, expression of foreign protein in CyHV-2 suggests that the fully attenuated mutant of CyHV-2 could potentially function as a viral vector for developing subunit vaccines or multivalent recombinant attenuated vaccines.
鲤疱疹病毒2型(CyHV-2)是一种病原体,由于鲫鱼和金鱼的大量死亡,给全球水产养殖业造成了重大损失。本研究表明,通过同源重组获得的ORF55/ORF57缺失突变体CyHV-2-Δ55-CP和CyHV-2-Δ57-CP在斜带石斑鱼鳍细胞(GiCF)的尾鳍内能够有效复制,并且呈现出与CyHV-2野生型菌株相似的形态。两种突变体均表现出毒力下降,其中CyHV-2-Δ57-CP的毒力下降更为显著。这为后续开发针对CyHV-2的重组减毒疫苗提供了参考。此外,两种突变体均表达插入的RGNNV-CP(神经坏死病毒的衣壳蛋白)融合蛋白基因,用感染CyHV-2-Δ57-CP的GiCF细胞裂解物进行接种可在石斑鱼体内引发抗体反应。这些结果表明,虽然CyHV-2的ORF55和ORF57基因在体外病毒复制中不是必需的,但它们在体内毒力方面确实发挥了作用。此外,CyHV-2中外源蛋白的表达表明,CyHV-2的完全减毒突变体可能潜在地用作开发亚单位疫苗或多价重组减毒疫苗的病毒载体。